Related Experiment Video
Updated: Jun 26, 2026
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Immunocorrecting properties of GB-115 dipeptide.
E V Shipaeva1, L P Kovalenko, S V Khaidukov
1V. V. Zakusov Institute of Pharmacology, Moscow.
The novel dipeptide GB-115, with anxiolytic properties, enhances immune responses in healthy mice and corrects immune deficiencies in cyclophosphamide-treated animals.
Area of Science:
- Immunology
- Pharmacology
- Neuroscience
Background:
- Secondary immunodeficiency can impair immune function.
- Dipeptides are being investigated for therapeutic potential.
- GB-115 is a novel dipeptide with demonstrated anxiolytic activity.
Purpose of the Study:
- To investigate the immunomodulatory effects of GB-115.
- To assess GB-115's impact on immune parameters in healthy and immunocompromised mice.
Main Methods:
- Administration of GB-115 (0.1-10 mg/kg) to intact and cyclophosphamide-induced immunodeficient mice.
- Evaluation of phagocytic activity of peritoneal macrophages.
- Assessment of humoral immune response.
Main Results:
- GB-115 stimulated macrophage phagocytic activity in intact mice.
- GB-115 enhanced humoral immune response in intact mice.
- GB-115 demonstrated immunocorrecting activity in mice with secondary immunodeficiency.
Conclusions:
- GB-115 possesses immunomodulatory properties.
- GB-115 may be a potential therapeutic agent for immune dysregulation.
- Further research into GB-115's mechanism of action is warranted.
More Related Videos
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
15:33Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013